health economist

Combined effect of ozone and household air pollution on COPD in people aged less than 50 years old
Zhenzhen Xing, Ting Yang, Su Shi, Xia Meng, Di Chai, WeiMing Liu, Yaqi Tong, Yuxia Wang, Yali Ma, MingMing Pan, Jia Cui, Huanyu Long, Tieying Sun, Renjie Chen, YanFei Guo

Thorax Jan 2024, 79 (1) 35-42; DOI: 10.1136/thorax-2022-219691
Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease
Amy Po Yu Tsai, Seo Am Hur, Alyson Wong, Mohsen Safavi, Deborah Assayag, Kerri A Johannson, Julie Morisset, Charlene Fell, Jolene H Fisher, Hélène Manganas, Shane Shapera, Gerard Cox, Andrea S Gershon, Nathan Hambly, Nasreen Khalil, Teresa To, Pearce George Wilcox, Andrew Halayko, Martin RJ Kolb, Christopher J Ryerson

Thorax Jan 2021, 76 (1) 37-43; DOI: 10.1136/thoraxjnl-2020-214944
Optimising breathlessness triggered services for older people with advanced diseases: a multicentre economic study (OPTBreathe)
Deokhee Yi, Charles C Reilly, Gao Wei, Irene J Higginson

Thorax May 2023, 78 (5) 489-495; DOI: 10.1136/thoraxjnl-2021-218251
Cost-effectiveness of home non-invasive ventilation in patients with persistent hypercapnia after an acute exacerbation of COPD in the UK
Patrick Brian Murphy, Bernd Brueggenjuergen, Thomas Reinhold, Qing Gu, Laura Fusfeld, Gerard Criner, Thomas F Goss, Nicholas Hart

Thorax May 2023, 78 (5) 523-525; DOI: 10.1136/thorax-2022-219653
Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease
Safa Ahmadian, Don D Sin, Larry Lynd, Mark Harrison, Mohsen Sadatsafavi

Thorax Nov 2022, 77 (11) 1079-1087; DOI: 10.1136/thoraxjnl-2021-217962
Tracking of lung function from 10 to 35 years after being born extremely preterm or with extremely low birth weight
Tonje Bårdsen, Ola Drange Røksund, Merete Røineland Benestad, Karl Ove Hufthammer, Hege Havstad Clemm, Ingvild Bruun Mikalsen, Knut Øymar, Trond Markestad, Thomas Halvorsen, Maria Vollsæter

Thorax Aug 2022, 77 (8) 790-798; DOI: 10.1136/thoraxjnl-2021-218400
Cost-effectiveness of ambulatory care management of primary spontaneous pneumothorax: an open-label, randomised controlled trial
Ramon Luengo-Fernandez, Filipa Landeiro, Rob Hallifax, Najib M Rahman

Thorax Sep 2022, 77 (9) 913-918; DOI: 10.1136/thoraxjnl-2021-218479
Higher SARS-CoV-2 detection of oropharyngeal compared with nasopharyngeal or saliva specimen for molecular testing: a multicentre randomised comparative accuracy study
Tobias Todsen, Martin G Tolsgaard, Thomas Benfield, Fredrik Folke, Kathrine K Jakobsen, Niels Tobias Gredal, Annette K Ersbøll, Christian von Buchwald, Nikolai Kirkby

Thorax Oct 2023, 78 (10) 1028-1034; DOI: 10.1136/thorax-2022-219599
Implementing non-invasive ventilation at home: the frontier for chronic respiratory failure?
Mark E Howard, Anna Ridgers

Thorax Jan 2023, 78 (1) 7-8; DOI: 10.1136/thorax-2022-219480
The at-risk registers in severe asthma (ARRISA) study: a cluster-randomised controlled trial examining effectiveness and costs in primary care
Jane Rebecca Smith, Michael J Noble, Stanley Musgrave, Jamie Murdoch, Gill M Price, Garry R Barton, Jennifer Windley, Richard Holland, Brian DW Harrison, Amanda Howe, David B Price, Ian Harvey, Andrew M Wilson

Thorax Dec 2012, 67 (12) 1052-1060; DOI: 10.1136/thoraxjnl-2012-202093

Main menu

health economist

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

health economist

Pages